Lead WP2a: Fritz R. Bühler, EFCPM, Switzerland
. Co-Lead: Mike Hardman, AstraZeneca, UK
WP 2 a.: Coordination, Collaboration, Strategies and New Programmes
Objectives
Take the lead and overall responsibility for the entire planning and execution of PharmaTrain. Liaise with IMI Training Programmes P15, P17 and P18 as well as integration of IMI-P16 into the IMI-P14, the European Medicines Research and Training Network EMTRAIN, to develop a pan-European pharma training platform
Define bottlenecks in the optimisation of the value chain of drug development, derive new training needs and translate these into training programmes for future implementation in concert with other IMI training programmes (Futures team conferences)
Develop a process for Novel Training Programmes to maximise the IMI-P16 experience.